Biomea Fusion宣布与莱斯特大学达成研究合作，评估Icovamenib联合司美格鲁肽治疗肥胖症

美股速递06-03

Biomea Fusion, Inc. (BMEA) 已与莱斯特大学建立研究合作伙伴关系，双方将共同探索其候选药物Icovamenib与司美格鲁肽联合用于肥胖症治疗的潜力。

这项合作旨在评估联合用药方案在对抗肥胖及相关代谢疾病方面的效果与机制。通过结合Biomea Fusion在创新疗法开发方面的专长与莱斯特大学在代谢研究领域的深厚学术积累，该研究有望为肥胖症治疗提供新的科学见解和潜在的治疗途径。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1113853657?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-06-03 20:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1113853657","market":"us","top_or_hot":-1,"title":"Biomea Fusion宣布与莱斯特大学达成研究合作，评估Icovamenib联合司美格鲁肽治疗肥胖症","media":"美股速递","content":"<p>Biomea Fusion, Inc. (BMEA) 已与莱斯特大学建立研究合作伙伴关系，双方将共同探索其候选药物Icovamenib与司美格鲁肽联合用于肥胖症治疗的潜力。</p>\n<p>这项合作旨在评估联合用药方案在对抗肥胖及相关代谢疾病方面的效果与机制。通过结合Biomea Fusion在创新疗法开发方面的专长与莱斯特大学在代谢研究领域的深厚学术积累，该研究有望为肥胖症治疗提供新的科学见解和潜在的治疗途径。</p>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biomea Fusion宣布与莱斯特大学达成研究合作，评估Icovamenib联合司美格鲁肽治疗肥胖症</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiomea Fusion宣布与莱斯特大学达成研究合作，评估Icovamenib联合司美格鲁肽治疗肥胖症\n</h2>\n\n<h4 class=\"meta\">\n\n2026-06-03 20:01 北京时间&nbsp;&nbsp;&nbsp;<strong>美股速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biomea Fusion, Inc. (BMEA) 已与莱斯特大学建立研究合作伙伴关系，双方将共同探索其候选药物Icovamenib与司美格鲁肽联合用于肥胖症治疗的潜力。\n这项合作旨在评估联合用药方案在对抗肥胖及相关代谢疾病方面的效果与机制。通过结合Biomea Fusion在创新疗法开发方面的专长与莱斯特大学在代谢研究领域的深厚学术积累，该研究有望为肥胖症治疗提供新的科学见解和潜在的治疗途径。</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"","article_id":"1113853657","we_media_id":"1004306016","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1113853657","pubTimestamp":1780488087,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"美股速递","introduction":"全球快讯第一时间播报","home_visible":1,"id":"1004306016","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Biomea Fusion, Inc. (BMEA) 已与莱斯特大学建立研究合作伙伴关系，双方将共同探索其候选药物Icovamenib与司美格鲁肽联合用于肥胖症治疗的潜力。\n这项合作旨在评估联合用药方案在对抗肥胖及相关代谢疾病方面的效果与机制。通过结合Biomea Fusion在创新疗法开发方面的专长与莱斯特大学在代谢研究领域的深厚学术积累，该研究有望为肥胖症治疗提供新的科学见解和潜在的治疗途径。\n","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","BMEA":"Biomea Fusion, Inc.","BK4539":"次新股","BK4585":"ETF&股票定投概念"},"translate_title":"Biomea Fusion announces research collaboration with the University of Leicester to evaluate Icovamenib in combination with semaglutide in the treatment of obesity","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMEA":1},"content_text":"Biomea Fusion, Inc. (BMEA) 已与莱斯特大学建立研究合作伙伴关系，双方将共同探索其候选药物Icovamenib与司美格鲁肽联合用于肥胖症治疗的潜力。\n这项合作旨在评估联合用药方案在对抗肥胖及相关代谢疾病方面的效果与机制。通过结合Biomea Fusion在创新疗法开发方面的专长与莱斯特大学在代谢研究领域的深厚学术积累，该研究有望为肥胖症治疗提供新的科学见解和潜在的治疗途径。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1113853657","isCrawlerRequest":true}